raremaprare-disease reference indexOrphadata 2026-06-23 · HPO 2026-09-01
ORPHA:435651

CIDEC-related familial partial lipodystrophy

Synonyms: CIDEC-related FPLD · FPLD5

Type
Disease
Group
Disorder
Inheritance
Autosomal recessive
Age of onset
Adolescent
Status
active

A rare, genetic lipodystrophy characterized by abnormal subcutaneous fat distribution, resulting in preservation of visceral, neck and axilliary fat and absence of lower limb and femorogluteal subcutaneous fat. Additional clinical features are acanthosis nigricans, insulin-resistant type II diabetes mellitus, dyslipidemia, and hypertension, leading to pancreatitis, hepatomegaly and hepatic steatosis.

1

Names in Orphadata languages

12 of 12 languages
LangNameSynonyms
enCIDEC-related familial partial lipodystrophyCIDEC-related FPLD · FPLD5
frLipodystrophie partielle familiale associée à CIDECFPLD5 · LDPF associée à CIDEC · LDPF5
deLipodystrophie, familiäre partielle, CIDEC-assoziierteCIDEC-abhängige FPLD · FPLD5
esLipodistrofia parcial familiar asociada a CIDECFPLD5
itLipodistrofia parziale familiare correlata a CIDECFPLD CIDEC-correlata
nlCIDEC-gerelateerde familiale partiële lipodystrofieCIDEC-gerelateerde FPLD · FPLD5
ptLipodistrofia parcial familiar CIDEC-relacionadaLipodistrofia parcial familiar associada a mutações no gene CIDEC
plRodzinna lipodystrofia częściowa zależna od CIDECFplD5 · FplD zależna od CIDEC
csCIDEC-vázaná familiární parciální lipodystrofieCIDEC-vázaná FPLD
ukСімейна часткова ліподистрофія, повязана з CIDECFPLD, повязані з CIDEC · FPLD5
zhCIDEC相关性家族性部分脂肪代谢障碍CIDEC相关的FPLD
trCIDEC-ilişkili ailesel kısmi lipodistrofiFPLD5 · CIDEC-ilişkili FPLD

Definition in:

2

Cross-references

qualifier = Orphanet mapping relation
SourceCodeQualifierICD relationValidation
OMIM615238Evalidated
ICD-10E88.1NTBTattributedvalidated
ICD-115A44NTBTattributedvalidated
MONDO0014098Evalidated
UMLSC3808940Evalidated

E exact · NTBT this ORPHAcode is narrower than the target · BTNT broader than the target · ND not decided.

3

Classification

Preferential parent (Orphanet linearisation):

Parents in the classifications (1):

No children.

4

Genes

1 direct
GeneAssociationStatusHGNCEnsemblOMIMLocusNameSource of validation
CIDECDisease-causing germline mutation(s) (loss of function) inAssessedHGNC:24229ENSG000001872886121203p25.3cell death inducing DFFA like effector c20049731[PMID]
5

Prevalence and incidence

2 records
TypeClassValueAreaQualificationValidationSource
Point prevalence<1 / 1 000 000—WorldwideClass onlyValidatedORPHANET_20049731[PMID]
Cases/families1 casesWorldwideCase(s)Validated20049731[PMID]

Value is Orphadata's ValMoy: the mean estimate per 100 000 for prevalence and incidence, the number of cases or families for case reports.

6

HPO phenotypes

16 annotations · validated 2016-12-28
HPOTerm (as annotated by Orphanet)Diagnostic
Obligate (100%)
HP:0009125Lipodystrophy
HP:0003635Loss of subcutaneous adipose tissue in limbs
Very frequent (99-80%)
HP:0000956Acanthosis nigricans
HP:0008981Calf muscle hypertrophy
HP:0030685Decreased adiponectin level
HP:0003292Decreased serum leptin
HP:0001397Hepatic steatosis
HP:0002240Hepatomegaly
HP:0002155Hypertriglyceridemia
HP:0000831Insulin-resistant diabetes mellitus
HP:0009017Loss of gluteal subcutaneous adipose tissue
HP:0000876Oligomenorrhea
HP:0001733Pancreatitis
HP:0000147Polycystic ovaries
HP:0003712Skeletal muscle hypertrophy
Excluded (0%)
HP:0000292Loss of facial adipose tissue

Run the differential on the 12 obligate / very frequent terms

Annotation source: 20049731[PMID]_18654663[PMID]

7

Sources for this card